Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Truls Gårdmark

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Urology|September 6, 2005
Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladderTruls Gårdmark, Malcolm Carringer, Eva Beckman, et al.
Scandinavian Journal of Urology and Nephrology|August 19, 2006
Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001Truls Gårdmark, Anna Bladström, Sverker Hellsten, et al.
BJU International|January 25, 2007
Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with high-risk bladder cancerTruls Gårdmark, Staffan Jahnson, Rolf Wahlquist, et al.
Scandinavian Journal of Urology|December 11, 2020
Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer - is there a long-term survival difference? A Swedish nationwide analysisEugen Y-H Wang, Ulf Larsson, Truls Gårdmark, et al.
Scandinavian Journal of Urology|May 16, 2022
Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based studyEugen Y H Wang, Nicklas Pihlström, Per-Uno Malmström, et al.
The Journal of Urology|May 31, 2019
A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014Dan-Olle Westergren, Truls Gårdmark, Lars Lindhagen, et al.
BJU International|April 21, 2005
Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastasesTruls Gårdmark, Kenneth Wester, Manuel De la Torre, et al.
Radiology and Oncology|March 27, 2015
EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclidesJörgen Carlsson, Kenneth Wester, Manuel De La Torre, et al.
Lakartidningen|February 12, 2024
[Radical cystectomy for bladder cancer is a complex procedure]Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, et al.
Cancer Medicine|August 28, 2020
A mediation analysis to explain socio-economic differences in bladder cancer survivalBeth Russell, Mieke V Hemelrijck, Truls Gårdmark, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Urology|September 6, 2005
Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladderTruls Gårdmark, Malcolm Carringer, Eva Beckman, et al.
Scandinavian Journal of Urology and Nephrology|August 19, 2006
Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001Truls Gårdmark, Anna Bladström, Sverker Hellsten, et al.
BJU International|January 25, 2007
Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with high-risk bladder cancerTruls Gårdmark, Staffan Jahnson, Rolf Wahlquist, et al.
Scandinavian Journal of Urology|December 11, 2020
Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer - is there a long-term survival difference? A Swedish nationwide analysisEugen Y-H Wang, Ulf Larsson, Truls Gårdmark, et al.
Scandinavian Journal of Urology|May 16, 2022
Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based studyEugen Y H Wang, Nicklas Pihlström, Per-Uno Malmström, et al.
The Journal of Urology|May 31, 2019
A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014Dan-Olle Westergren, Truls Gårdmark, Lars Lindhagen, et al.
BJU International|April 21, 2005
Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastasesTruls Gårdmark, Kenneth Wester, Manuel De la Torre, et al.
Radiology and Oncology|March 27, 2015
EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclidesJörgen Carlsson, Kenneth Wester, Manuel De La Torre, et al.
Lakartidningen|February 12, 2024
[Radical cystectomy for bladder cancer is a complex procedure]Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, et al.
Cancer Medicine|August 28, 2020
A mediation analysis to explain socio-economic differences in bladder cancer survivalBeth Russell, Mieke V Hemelrijck, Truls Gårdmark, et al.
Pageof 5